1. Laboratory biomarkers associated with COVID-19 severity and management.
- Author
-
Keddie S, Ziff O, Chou MKL, Taylor RL, Heslegrave A, Garr E, Lakdawala N, Church A, Ludwig D, Manson J, Scully M, Nastouli E, Chapman MD, Hart M, and Lunn MP
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers blood, COVID-19 blood, COVID-19 therapy, COVID-19 virology, Cytokine Release Syndrome blood, Cytokine Release Syndrome therapy, Cytokine Release Syndrome virology, Female, Hospitalization, Humans, Interleukin-10 blood, L-Lactate Dehydrogenase blood, Male, Middle Aged, Respiration, Artificial, Respiratory Distress Syndrome blood, Respiratory Distress Syndrome therapy, Respiratory Distress Syndrome virology, Risk Factors, Severity of Illness Index, C-Reactive Protein metabolism, COVID-19 diagnosis, Cytokine Release Syndrome diagnosis, Interleukin-6 blood, Respiratory Distress Syndrome diagnosis, SARS-CoV-2 pathogenicity
- Abstract
The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi-organ failure and death. Identification of high-risk cases will enable appropriate intervention and escalation. This study investigates the routine laboratory tests and cytokines implicated in COVID-19 for their potential application as biomarkers of disease severity, respiratory failure and need of higher-level care. From analysis of 203 samples, CRP, IL-6, IL-10 and LDH were most strongly correlated with the WHO ordinal scale of illness severity, the fraction of inspired oxygen delivery, radiological evidence of ARDS and level of respiratory support (p ≤ 0.001). IL-6 levels of ≥3.27 pg/ml provide a sensitivity of 0.87 and specificity of 0.64 for a requirement of ventilation, and a CRP of ≥37 mg/l of 0.91 and 0.66. Reliable stratification of high-risk cases has significant implications on patient triage, resource management and potentially the initiation of novel therapies in severe patients., (Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF